Okta upgraded, Datadog downgraded: Wall Street's top analyst calls
Scotiabank upgraded Okta to Outperform ($165) and Datadog’s peer set (SentinelOne, Qualys, Tenable, Check Point) to Outperform; BofA upgraded T-Mobile to Buy ($220); HSBC upgraded Gilead to Buy ($155) and downgraded Allstate to Hold ($264) and Chubb to Hold. Bernstein downgraded Datadog to Market Perform ($226). Multiple other analyst rating changes and new coverages were issued across airlines, banks, retail, and energy.
How this was made
The 30-second read
Why it matters
The actionable signal is the directionality of rating/target changes and the specific cited risks (notably Datadog’s Q3/beyond demand caution and JetBlue’s convertible constraint). However, there are no new company filings, earnings prints, or contract/regulatory events in the text.
Market read
Traders may use the note cycle for short-term positioning and relative-value trades, but conviction is limited because the article contains no fresh operational datapoints beyond analyst theses.
What to watch
For the downgrades, watch for whether the cited demand/guidance caution is later confirmed by actual prints; for upgrades, verify whether the ‘tracking high-end guidance’ claim is supported by upcoming company disclosures.
Background
This is a multi-stock analyst actions roundup (upgrades/downgrades and price targets) from several banks, with theses spanning AI cybersecurity spend, telecom partnership value, HIV adherence dynamics, fuel margins, and earnings-expectations caution.
Ticker impact
Scotiabank upgraded Okta to Outperform and set a $165 target, citing AI-driven cybersecurity spend and identity-stack modernization.
Mild-to-moderate upside bias around the note; follow-through depends on upcoming earnings/demand signals.
The article provides a clear rating/target change with a specific thesis, but no new Okta operational datapoint (e.g., guidance, bookings, product results).
Bernstein downgraded Datadog to Market Perform and raised its target to $226, citing Q3/beyond earnings caution and slowing demand signals.
Near-term downside or underperformance risk versus peers, especially if the market had priced in stronger Q3.
The thesis is specific (slowing enterprise/AI Labs demand), but the article lacks new Datadog metrics or guidance changes.
BofA upgraded T-Mobile to Buy with a $220 target, arguing the market overreacts to peak concerns and highlighting strategic partnership value.
Moderate upside bias; magnitude likely limited without new carrier KPIs or guidance.
Clear rating/target change with concrete rationale, but no fresh TMUS operational disclosure in the text.
HSBC upgraded Gilead to Buy and lifted its price target to $155, saying the market is too pessimistic post-dolutegravir generics and expecting long-acting adherence benefits.
Mild-to-moderate upside bias; could fade if upcoming trial/commercial data don’t confirm the offset.
The article provides a thesis but no new clinical/commercial data; pharma read-through is highly dependent on forthcoming evidence.
Goldman Sachs upgraded Murphy USA to Neutral from Sell with a $550 target, attributing the view to falling crude supporting fuel margins and EBITDA delivery.
Stabilization/limited upside potential; less likely to drive a large move without crude/margin confirmation.
Macro input (crude) is referenced but the article doesn’t provide new MUSA-specific margin data.
Jefferies upgraded U.S. Bancorp to Buy and raised its target to $75, citing tracking toward high-end NII/fee guidance plus operating leverage and an Amazon partnership.
Moderate upside bias if investors align with the high-end guidance/operating leverage framing.
The article references specific guidance tracking and catalysts (Amazon partnership, BTIG acquisition), but still no new bank print or updated guidance.
Raymond James downgraded Delta Air Lines to Outperform from Strong Buy with a $104 target, noting a recent rally reduced near-term valuation upside despite positives.
Potential relative underperformance versus other airlines if the market was chasing valuation upside.
The article’s key change is the rating/valuation-upside framing; no new Delta operational data is provided.
Raymond James downgraded JetBlue to Underperform, saying shares are constrained by the ~$6.12 conversion price of its convertible debt.
Downside/underperformance risk versus peers until capital structure overhang is resolved.
The convertible-debt constraint is a concrete, company-specific factor mentioned in the text, though no new financing event is disclosed.
Market effects
Cybersecurity/identity names (OKTA, S, QLYS, TENB, CHKP, CHKP) get a spend/AI beneficiary read-through; Datadog’s downgrade flags enterprise/AI demand caution.
Primarily US-listed large/mid-cap sentiment; no explicit regional macro catalyst beyond analyst framing.
Pharma (GILD) and energy-linked margin narratives (MUSA) reflect global demand/price assumptions rather than new global events.
Counterpoint
Analyst upgrades/downgrades may be more about valuation and expectations management than new fundamentals; the market may already price the thesis, limiting follow-through.
Key entities
- companyOkta
Upgraded to Outperform with a $165 target; framed as an AI beneficiary of rising cybersecurity spend.
- companyDatadog
Downgraded to Market Perform; Bernstein cites slowing enterprise and AI Labs demand into Q3 and beyond.
- companyT-Mobile
Upgraded to Buy with a $220 target; BofA says the market overreacts to peak concerns.
